Mr. Speaker, I appreciate that; however, it does not answer the question I asked.
There were reports today that an individual living in Canada experienced rare blood clotting following immunization with the AstraZeneca vaccine. Other countries, including Australia, have announced that they are suspending use.
Given this information, has the minister consulted with her officials? Does she anticipate that advice on AstraZeneca usage will be changed? Why or why not? If so, when will she be providing that advice publicly?